24.06.2015 • NewsDede Willamsprescriptionprofits

Americans Blame Drugmakers for High Prices

© Nikolai Sorokin - Fotolia.com
© Nikolai Sorokin - Fotolia.com

Americans are far more likely to blame pharmaceutical companies for high prescription medication costs than their health insurers, a recent poll has found. Of the 1,200 adults interviewed by the Kaiser Family Foundation’s researchers for the June Kaiser Health Tracking Poll, around three-quarters said the cost of prescription drug costs was unreasonable, but only10% of those responding blamed the high prices on co-pays demanded by their insurance company.

A similar majority said drug profits were a major factor in prescription prices, and 87% approved of enabling the Medicare program to negotiate prices with producers.

At the same time, over 70% of the poll’s respondents said they thought insurers should always pay for an expensive drug recommended by a doctor when no lower-cost alternative exists.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.